References
- Franco OH, Peeters A, Bonneux L, de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women. Hypertension. 2005;46:280–286.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003; 289:2560–2572.
- ALLHAT Collaborative research group. Major cardiovascular events in hypertensive patients randomized to doxazocin vs chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc. 2000;283:1967–1975.
- Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Scherstén B. Randomized trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old patients with Hypertension-2 study. Lancet. 1999;354:1751–1756.
- Frishman WH, Hainer JW and Sugg J for the M-FACT Study Group. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate– Felodipine Antihypertension Combination Trial (M-FACT). AJH. 2006;19:388–395.
- Papademetriou V, Hainer JW, Sugg J, Munzer D for the ATTACH Study Group. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination. AJH. 2006;19:1217–1225.
- Dezii CM. A retrospective study of persistence with single pill combination therapy vs. concurrent two pill therapy in patients with hypertension. Manag Care. 2000;9 Suppl 9:S2–S6.
- Burnier M. Medication adherence and persistence as the cornerstone effective antihypertensive therapy. Am J Hypertension. 2006;19:1190–1196.
- Klein G, for the German felodipine study group. Long-term evaluation of the fixed combination of felodipine and metoprolol in the treatment of hypertension. Curr Ther Res. 1992;52:238–242.
- Cook NR, Cohen J, Hebert PR, Taylor Jo, Honnekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155:701–709.
- Westergren G, Olofsson B and Parlevliet K. Effective once-daily treatment of hypertension with low-dose, controlled release metoprolol. Curr Ther Res. 1994;55:142–148.
- Haria M, Plosker GL, Markham A. Felodipine/metorolol, a review of the fixed dose controlled formulation in the management of essential hypertension. Drugs. 2000;59:141–157.
- Dahlof B, Jonsson L, Borgholst O, Ekblad G, Engstrand C, Grundestam I, . Improved antihypertensive efficacy of the felodipine metoprolol extended release tablet compared with each drug alone. Blood Press. 1993;2 Supp l:37–45.
- Hoffmann J. Comparison of a felodipine–metoprolol combination tablet vs each component alone as antihypertensive therapy. Blood Press. 1993;2 Suppl 1:30–36.